SCHEMBL5147135

SCHEMBL5147135

NC(=O)Nc1ccc(-n2c3c(c4ccccc42)C(=O)CCC3)c(Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
GRM4 Q14833 5/20 0.39
PTGS1 P23219 1/20 0.37
PTGS2 P35354 1/20 0.37
TP53 P04637 2/20 0.37
CREBBP Q92793 1/20 0.37
OPRM1 P35372 1/20 0.36
MAOB P27338 1/20 0.36
KDM4E B2RXH2 1/20 0.36
RECQL P46063 1/20 0.36
RAB9A P51151 6/20 0.35
ALDH1A1 P00352 5/20 0.35
MAPT P10636 4/20 0.35
NPC1 O15118 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
NFKB1 P19838 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5148480 0.90 PTGS1 (0.44) HDAC1HDAC6GRM4PTGS1PTGS2
SCHEMBL5147134 0.90 LMNA (0.45) HDAC1HDAC6GRM4PTGS1PTGS2
SCHEMBL14422443 0.88 TP53 (0.41) HDAC1HDAC6GRM4TP53CREBBP
SCHEMBL5145355 0.87 GRM4 (0.35) GRM4TP53MAOBKDM4ERECQL
SCHEMBL5145359 0.87 GRM4 (0.35) GRM4TP53MAOBKDM4ERECQL
SCHEMBL5147107 0.87 CYP2D6 (0.48) HDAC1HDAC6RAB9AALDH1A1MAPT
SCHEMBL5148161 0.86 TP53 (0.41) HDAC1HDAC6GRM4PTGS1PTGS2
SCHEMBL5145428 0.85 DOT1L (0.45) HDAC1HDAC6GRM4PTGS1PTGS2
SCHEMBL5147078 0.85 HDAC1 (0.48) HDAC1HDAC6GRM4PTGS1PTGS2
SCHEMBL5145476 0.84 BRD4 (0.42) GRM4CREBBPMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
CN-101268048-A Carbazole derivatives SERENEX INC (US) 2008-09-17 CN disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885GRM4 3565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.